Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.967
+0.027 (2.87%)
Dec 30, 2024, 4:00 PM EST - Market closed
Kronos Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 9.86 | 6.29 | - | - | - | - | Upgrade
|
| Gross Profit | 9.86 | 6.29 | - | - | - | - | Upgrade
|
| Selling, General & Admin | 32.19 | 42.35 | 46.47 | 41.8 | 19.07 | 3.37 | Upgrade
|
| Research & Development | 55.69 | 81.16 | 90.65 | 109.6 | 38.98 | 13.45 | Upgrade
|
| Operating Expenses | 87.88 | 123.51 | 137.12 | 151.4 | 58.04 | 16.82 | Upgrade
|
| Operating Income | -78.02 | -117.22 | -137.12 | -151.4 | -58.04 | -16.82 | Upgrade
|
| Interest Expense | -1.67 | - | - | - | -3.89 | -0 | Upgrade
|
| Interest & Investment Income | - | - | - | 0.32 | 0.9 | 0.7 | Upgrade
|
| Other Non Operating Income (Expenses) | 9.41 | 9.41 | 3.91 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -70.28 | -107.81 | -133.2 | -151.08 | -61.04 | -16.12 | Upgrade
|
| Merger & Restructuring Charges | -7.91 | -1.71 | - | - | - | - | Upgrade
|
| Asset Writedown | -7.4 | -3.15 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -27.41 | - | Upgrade
|
| Pretax Income | -85.59 | -112.67 | -133.2 | -151.08 | -88.44 | -16.12 | Upgrade
|
| Net Income | -85.59 | -112.67 | -133.2 | -151.08 | -88.44 | -16.12 | Upgrade
|
| Net Income to Common | -85.59 | -112.67 | -133.2 | -151.08 | -88.44 | -16.12 | Upgrade
|
| Shares Outstanding (Basic) | 60 | 58 | 56 | 55 | 16 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 58 | 56 | 55 | 16 | 5 | Upgrade
|
| Shares Change (YoY) | 3.92% | 2.75% | 2.64% | 236.38% | 208.35% | 8.69% | Upgrade
|
| EPS (Basic) | -1.44 | -1.95 | -2.37 | -2.76 | -5.43 | -3.05 | Upgrade
|
| EPS (Diluted) | -1.44 | -1.95 | -2.37 | -2.76 | -5.43 | -3.05 | Upgrade
|
| Free Cash Flow | -77.66 | -79.26 | -91.5 | -122.18 | -47.48 | -18.03 | Upgrade
|
| Free Cash Flow Per Share | -1.30 | -1.37 | -1.63 | -2.23 | -2.92 | -3.42 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | - | - | - | - | Upgrade
|
| Operating Margin | -790.92% | -1864.14% | - | - | - | - | Upgrade
|
| Profit Margin | -867.66% | -1791.87% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -787.26% | -1260.51% | - | - | - | - | Upgrade
|
| EBITDA | -76.23 | -115.08 | -134.85 | -149.42 | -57.21 | -16.46 | Upgrade
|
| D&A For EBITDA | 1.79 | 2.14 | 2.27 | 1.98 | 0.84 | 0.36 | Upgrade
|
| EBIT | -78.02 | -117.22 | -137.12 | -151.4 | -58.04 | -16.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.